Targeting the Burden of Moderate to Severe Psoriasis: A Visual Exploration of the Role of IL-17 Inhibitors in Improving Patient Care and Quality of Life

0.50 hr(s) | CME

Specialty: Psoriasis

Therapeutic Area(s): Dermatology

Release Date: March 25, 2021

Expiration Date: March 24, 2022

Location: Internet Activity Enduring

In this activity, an expert in dermatology discusses the role of IL-17 inhibitors in the treatment of psoriasis.

Access this activity
Share via
Copy link
Powered by Social Snap